Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of recombinant human growth hormone cotreatment during long GnRH agonist ovarian stimulation in women with previous poor ovarian response
2010-022151-32Phase 2Active
- Sponsor
- Fundació Santiago Dexeus Font
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of somatropin in poor ovarian response (POR) (2 arms), sponsored by Fundació Santiago Dexeus Font. Primary endpoint: Number of metaphase II oocytes. Started Jan 2011; status: active.
02
Drugs
somatropin
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on 2010-022151-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022151-32.